Hidden renal disease in a female patient with long-lasting isolated gestational proteinuria followed by hypertension

HTML  XML Download Download as PDF (Size: 160KB)  PP. 680-682  
DOI: 10.4236/ojog.2013.39124    4,045 Downloads   5,785 Views  

ABSTRACT

Background: The prevalence of asymptomatic renal scarring, such as a focal segmental glomerulosclerosis (FSGS), was suggested to be high in women who develop preeclampsia. FSGS is a risk factor for endstage renal disease. Objective: To document preeclamptic women with proteinuria that developed eight weeks prior to hypertension with confirmed FSGS postpartum. Case: A 20-year-old nulliparous Japanese woman with a negative dipstick test result at gestational week (GW) 18 exhibited proteinuria 1+ on dipstick test at GW 22. Proteinuria determined from the random urine protein to creatinine ratio (P/Cr, g/g) was increased from 3.7 at GW 26 to 4.6 and 8.9 at GW 28 and 30, respectively. She developed hypertension (142/66 mmHg) at GW 30. Due to increased edema, emergency cesarean section was performed at GW 33. She gave birth to an otherwise healthy female small-for-gestational-age infant, weighing 1290 g. Postpartum course was uneventful except for persisting proteinuria: P/Cr of 9.8 just before delivery decreased to 3.6 and 1.7 on postpartum weeks 9 and 17, respectively. Renal biopsy on postpartum week 13 revealed FSGS in this patient. Conclusion: Hidden FSGS may have manifested as preeclampsia in this patient. This case highlighted the need to determine the prevalence of asymptomatic FSGS among women who later develop preeclampsia.

Share and Cite:

Kawabata, K. , Akaishi, R. , Nozaki, A. , Sato, O. , Hanatani, K. and Minakami, H. (2013) Hidden renal disease in a female patient with long-lasting isolated gestational proteinuria followed by hypertension. Open Journal of Obstetrics and Gynecology, 3, 680-682. doi: 10.4236/ojog.2013.39124.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.